Ginkgo Bioworks DNA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ginkgo Bioworks's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ginkgo Bioworks's operating income?
- Ginkgo Bioworks (DNA) reported operating income of -$71.37M in Q1 2026.
- How has Ginkgo Bioworks's operating income changed year-over-year?
- Ginkgo Bioworks's operating income increased by 11.9% year-over-year, from -$80.97M to -$71.37M.
- What is the long-term trend for Ginkgo Bioworks's operating income?
- Over 4 years (2021 to 2025), Ginkgo Bioworks's operating income has grown at a -36.0% compound annual growth rate (CAGR), from -$1.83B to -$307.28M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.